Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing

by Ambrose, Christopher S.
Published 2012

Statistical Power to Detect an Association Between Guideline-based Palivizumab Administration and Hospitalizations for Respiratory Syncytial Virus Infections

by Ambrose, Christopher S.
Published in Pediatr Infect Dis J (2017)

Is it RSV?

by Ambrose, Christopher S.
Published in Health Sci Rep (2018)

Factors associated with increased vaccination in 2009 H1N1 school-located influenza vaccination programs

by Ambrose, Christopher S, Sifakis, Frangiscos
Published 2011

Current experience with school-located influenza vaccination programs in the United States: A review of the medical literature

by Hull, Harry F, Ambrose, Christopher S
Published 2011

The rationale for quadrivalent influenza vaccines

by Ambrose, Christopher S., Levin, Myron J.
Published 2012

Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines

by Woo, Jennifer C., Ambrose, Christopher S.
Published in Influenza Other Respir Viruses (2009)

A multi‐season national estimate of adult influenza vaccination by US office‐based pediatricians, 2006–2011

by Toback, Seth. L., Ambrose, Christopher S.
Published in Influenza Other Respir Viruses (2011)

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza

by Ambrose, Christopher S., Luke, Catherine, Coelingh, Kathleen
Published 2008

An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2–17 years

by Ambrose, Christopher S., Yi, Tingting, Falloon, Judith
Published 2011

The Medicaid Cost of Palivizumab

by Ambrose, Christopher S., McLaurin, Kimmie K.
Published in J Pediatric Infect Dis Soc (2015)

Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines

by Ambrose, Christopher S, Bright, Helen, Mallory, Raburn
Published in Euro Surveill (2016)

737. The Prevalence of Diagnosed Chronic Lung Disease in US Infants by Gestational Age: Implications for RSV Policy

by Ambrose, Christopher S, Jiang, Xiaohui, Mavunda, Kunjana
Published in Open Forum Infect Dis (2018)

1401. Real-World Effectiveness of Inactivated and Live Attenuated Influenza Vaccines in Children During Three Recent Seasons: 2016–2019

by Bandell, Allyn, Mallory, Raburn, Ambrose, Christopher S
Published in Open Forum Infect Dis (2020)

A population-weighted, condition-adjusted estimate of palivizumab efficacy in preventing RSV-related hospitalizations among US high-risk children

by Ambrose, Christopher S, Chen, Xin, Kumar, Veena R
Published in Hum Vaccin Immunother (2014)

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

by Ambrose, Christopher S., Levin, Myron J., Belshe, Robert B.
Published 2010

1973. A Meta-Analysis of the Effectiveness of LAIV4 and IIV against Influenza A/H3N2 Strains in Children 2–18 Years of Age During the 2016–2017 Season

by Mallory, Raburn, Bandell, Allyn, Ambrose, Christopher S, Yu, Jing
Published in Open Forum Infect Dis (2018)

Pituitary apoplexy and associated cranial nerve palsies secondary to bleeding caused by immune thrombocytopaenia in a patient with known pituitary macroadenoma

by Ambrose, Christopher, Sarma, Sruthi, Banerjee, Ritwick, Myers, Sam
Published in BMJ Case Rep (2021)

A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children

by Caspard, Herve, Heikkinen, Terho, Belshe, Robert B., Ambrose, Christopher S.
Published in Hum Vaccin Immunother (2016)

Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis

by Caspard, Herve, Mallory, Raburn M., Yu, Jing, Ambrose, Christopher S.
Published in Open Forum Infect Dis (2017)